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Introduction
Over the years, there has been a shift towards
operating children with ventricular septal defects (VSD)
earlier. This trend may be explained mainly by two
observations: Firstly, pediatric cardiologists are referring
patients to surgeons for repair of symptomatic VSDs as early
as possible and secondly, an increase in the awareness of the
general population, has led to a greater and earlier influx of
patients compared to the past.  
Ventricular septal defect (VSD) is one of the most
common congenital heart defect, accounting for 25% to 30%
of all children born with structural heart disease.1 Large VSDs
cause significant morbidity and mortality in infants because of
congestive heart failure and recurrent lung infections. If left
untreated, large VSDs typically result in significant failure to
thrive, which often does not respond to nutritional
supplementation alone.2-4 Delay in closure of large VSDs
during infancy is also associated with a risk for development
of pulmonary vascular obstructive disease.5 Usually, infants
can be haemodynamicaly stable if the surgery is performed
before the age of 6 to 9 months.5-7 Studies from developed
countries have demonstrated that adverse preoperative factors
do not significantly affect the postoperative outcome of infants
undergoing VSD closure.8-14 It is also known that earlier
intervention prevents these patients from heart failure and
helps to maintain proper development and growth without
increased pulmonary resistance.  
However, in developing countries, there is a clear
difference with respect to the patient population. Usually,
patients with VSDs present very late, often several months to
years after they start developing symptoms. This exposes them
preoperatively to a high risk from a cardiac point of view and
also predisposes them to recurrent lung infections. Moreover,
environmental and nutritional factors expedite the development
of such risks as most of these patients come from under-
privileged classes with poor hygiene and parallel malnutrition.
Concern about the postoperative complications is also one of
the major hindrances to early surgery. However, the trend is
changing as the public is getting more aware of the
developments and technologies of health sector as a result of
better health awareness programmes. This has led to an increase
in the number of infants with VSDs being referred for surgery. 
To address this debate and evaluate the effectiveness of
early VSD repair, we compared the outcomes of VSD closure
in different age groups.
Methods 
The study was conducted retrospectively at the Aga
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Abstract
Objective: To assess and evaluate the effectiveness of early ventricular septal defect (VSD) repair in a
developing country by comparing the outcomes in two age groups.
Methods:  A total of 39 patients underwent VSD repair at a tertiary care hospital in Karachi over a period of 2.5
years. Patients were divided into Group 1 (< 2 years) and Group 2 (2-18 yrs). Perioperative and postoperative
variables were reviewed retrospectively for each patient and compared with the development of complications
and the effect on postoperative recovery times. The data was analyzed using Mann Whitney test for continuous
variables and Fischer's exact test for categorical variables.
Results: Mean age at surgery was 10.1 ± 7.0 months and 108.5 ± 54.0 months for both groups, respectively.
Two patients died. Procedure time was not affected by decreasing age (p=0.622) but Cardio pulmonary Bypass
duration (p=0.040) and Aortic Cross Clamp time (p=0.063) were significantly affected. No associated significance
was obtained when hospital stay (p=0.085) was observed. Increased duration of ventilation (p=0.000) and length
of ICU stay (p=0.003) were highly significant for the younger age group. Presence of residual VSD (p=0.025)
was also significantly affected by lower age. There was no significant difference in the number of patients with
complications (p=1.000) among the 2 groups.
Conclusion: Age does not increase morbidity rates after VSD repair although postoperative recovery times are
increased with decreasing age. Hence, there is no justification in delaying VSD repair (JPMA 60:324; 2010).
Khan University Hospital, a tertiary care hospital in Karachi,
Pakistan, for a period of 2.5 years, from July 2006 to
December 2008. We reviewed preoperative, operative and
postoperative data from the medical records of the patients,
and comparisons were made thereafter to observe the
outcomes. A total of 39 patients underwent VSD closures that
were divided into two groups based on their ages: Group 1 (n
= 21, <2yrs of age) and Group 2 (n = 18, 2-18 yrs of age).
Patients with single as well as multiple VSDs were included,
as were infants with associated Atrial Septal Defect (ASD),
Patent Ductus Arteriosus (PDA), Aortic Regurgitation (AR),
Double Outlet Right Ventricle (DORV) and Coarctation of
Aorta (CoA).  Patients with atrioventricular canal defects,
Tetralogy of Fallot and other concomitant defects were
excluded from the analyses. 
The following variables were collected from each
patient's medical record: patient's first and last name, medical
record number (unique to each patient in the AKUH clinical
database), date of birth, sex, height and weight.
The pre-operative echo data which included type of
VSD, any concomitant defects and the size of VSD were
obtained.
Hospital data included date of surgery and date of
discharge (to calculate the length of hospital stay), previous
pulmonary artery banding, use of any medications, and
evaluation with right heart catheterization (RHC) and
comparison with the echocardiogram.
Operative variables included duration of surgery (time
from incision to time of dressing), Cardiopulmonary bypass
(CPB) time and aortic cross clamp (ACx) time were recorded
where ACx is inclusive of CPB time. Minimum temperature
achieved during surgery, type of VSD closure and the
approach used by the surgeon were also among the data
obtained.
Post-operative data included the presence of any
residual VSD/s (through a post-op echo), the type of residual
VSD, any inotropic support required by the patient, duration
of ventilation, length of ICU stay and any complications that
occurred postoperatively.
All data for each patient was collected by 2
independent investigators. Upon completion, both the
investigators randomly selected 1 in 10 medical record files
and quality controlled them by verifying the information a
second time. 
The data was not normally distributed and was
analyzed for group differences using nonparametric methods.
The data is presented as arithmetic mean ± standard deviation.
The chosen p value was two tailed, and a p value of < 0.05 was
considered significant. Continuous variables such as duration
of surgery, CPB time etc were analyzed using Mann Whitney
test and categorical variables such as presence of
complications, presence of residual VSDs, etc were analyzed
using Fisher's exact test (equivalent of chi-square for non-
normally distributed data).
Results
The results are summarized in Table-1. The mean age
at the time of surgery for group 1 was 10.1 ± 7.0 months and
for group 2 was 108.5 ± 54.0 months.  VSDs were categorized
as membranous/perimembranous (76.9%), inlet type (5.1%),
outlet type (0) and muscular (17.9%). None of the patients had
a combination of these VSDs. The most common associated
defect was PDA (50%), second to which was ASD (35.9%).
The size of VSD was 8.6 ± 2.3 mm and 9.4 ± 5.3 mm for both
groups, respectively which was not associated with decreasing
age (p=0.691). 
Operative data included CPB, ACx and surgery times.
Duration of surgery was not affected by increasing age
(p=0.622) but CPB (p=0.040) and ACx time (p=0.063) were
significantly affected by decreasing age. There was a tendency
for younger age group to have a longer CPB and ACx times,
as shown in Table-1.  Postoperative data included duration of
ventilation, length of ICU and hospital stay. No associated
significance was obtained when looked at the hospital stay
(p=0.085), although there was increase in the duration of
ventilation (p=0.000) and the length of ICU stay (p=0.003)
with increasing age which were very highly significant. 
Other postoperative variables included the presence of
residual VSD and complications. The presence of residual
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Table-1:  Summary of the variables.
Group I* Group II p value+
n = 21 n = 18
Preoperative variables
Height (cm) 69.5 ± 26.4++ 127 ± 25.2
Weight (kg) 6.6 ± 4.0 27.2 ± 13.6
Age (months) 10.1 ± 7.0 108.5 ± 54.0
Size of VSD (mm) 8.6 ± 2.3 9.4 ± 5.3 0.691
Operative variables+++ 
Duration of surgery (min) 234.5 ± 72.4 234.9 ± 58.9 0.622
CBP time (min) 121.9 ± 37.2 99.6 ± 35.2 0.040
Aortic cross clamp time (min) 69.4 ± 26.1 54.3 ± 22.0 0.063
Postoperative variables
Duration of ventilation (hr) 65.8 ± 32.0 14.0 ± 33.4 0.000
Length of ICU stay (hr) 136.6 ± 145.9 63.2 ± 33.0 0.003
Length of Hospital stay (days) 7.3 ± 5.6 5.6 ± 2.5 0.085
Postoperative results
Complications (%) 66.7 (14)# 66.7 (12) 1.000
Residual VSDs (%) 66.7 (14) 27.8 (5) 0.025
*Age groups
+p<0.05 is considered significant
++A.M. ± S.D. (95% CI)
+++Anaesthesia time not included
# (n)
VSD (p=0.025) was significantly decreased by increasing age
(more older patients with residual VSD). On postoperative
echocardiography, all those patients who had residual VSDs
(n= 19) were found to be of residual-patch margin type and
none had a residual VSD > 2 mm in size. None of the patients
required reoperation for residual VSD/s in the early post-
operative period. There were 62 adverse events in 26 patients
including postoperative fever >38°C (n=9) which was
managed effectively, readmission within 30 days of surgery
(n=3), re-intubation (n=6) and cardiac arrest (n=3). In the case
of cardiac arrest, patients were revived after defibrillation
except one who contributed towards mortality as well. There
were 2 mortalities, one male and one female, of ages 5 months
each with weights 3.7 kg and 4.1 kg, respectively. Both of
these patients were severely ill preoperatively and never
recovered, ultimately dying secondary to multi-organ failure.
There were no patients with heart block requiring temporary
or permanent pacing. Few patients developed pleural effusion
requiring drainage (n=5) and pericardial effusion requiring
drainage (n=4) who developed no further complications.
There was no case of chylothorax or arrhythmias. Even
though the total number of complications were significantly
different in both the groups; Group I (n=43) and Group II
(n=19), as shown in Table-2; there was no significant
difference in the number of patients who encountered
complications (p=1.000) among the 2 groups. In Group I and
Group II there were 13 out of 21 and 11 out of 18 patients who
had complications, respectively. This was possible as some of
the patients had more than one complication, Group I (n=9)
and Group II (n=6). On analysis, there was no significant
difference (p=0.431) between the groups with respect to the
presence of more than one complication. This is explained, in
detail, in Table-3.
Discussion
There is little published information from the
developing world to assess and evaluate the effectiveness of
early VSD repair. The purpose of this study was to compare
the outcomes of VSD repair in infants with non-infants,
primarily focusing on the development of complications
postoperatively and postoperative care. 
The preoperative characteristics of our study sample
clearly reflect the kind of patient population we encounter.
Almost half of the study sample in each category proved the
later influx of VSD patients. Even in Group 1, the mean age
of the patients who presented with VSDs was 10.1 ± 7.0
months, which is late when looked at the recommended
timeline. Usually, when children reach 6 months of age with a
large, single VSD, elective surgery is warranted.5,15,16 The
indications for surgical closure of a VSD, uncomplicated by
other congenital cardiac defects, depend on the size of the
defect and its haemodynamic consequences.17 In the absence
of significant symptoms, surgical closure can be delayed
because pulmonary vascular obstructive disease rarely
develops > 2 years.15,17 Nevertheless, there are many
exceptions to this rule, and it is difficult to predict which
children will develop an early and accelerated form of
pulmonary vascular disease.15
Occasionally, these children will suffer from severe,
intractable congestive heart failure despite aggressive in-
hospital medical treatment and require early surgical
intervention within the first or second month of life.16
Children become increasingly tachypnoeic, particularly
related to feeding, and fail to gain weight. Left untreated, they
are likely to fail to thrive and progressively fall off the growth
curve.15 These children must be referred for early surgery as
they become progressively symptomatic within the first 6
months. And as long as the repair is done before the
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Table-2: Frequency of all complications observed.
Complications Group I Group II Total
SVT 0 0 0
Atrial flutter 0 0 0
Junctional rhythm 0 2 2
Bradycardia 5 0 5
Blood loss requiring transfusion 4 1 5
Transfusion without blood loss 3 1 4
Wound infection 2 0 2
Haemodynamics
Hypotension 4 1 5
Metabolic acidosis 1 0 1
Cardiac arrest 2 1 3
Fever > 38°C 3 6 9
Multiorgan failure 1 0 1
Readmission (within 30 days) 1 2 3
Post op sepsis 1 0 1
Pneumonia 3 1 4
Reintubation 5 1 6
Chylothorax 0 0 0
Pleural effusion 4 1 5
Pericardial effusion 2 2 4
Death 2 0 2
Total 43 19 62
Table-3: Detail of the pattern of the complications observed.
Group I Group II Total
n > 1* 9 8 17+
n = 1++ 5 4 9+++
n = 0# 7 6 13**
GC*** 14 12
Total**** 21 18 39
* No. of patients with more than one complication
+ Total no. of patients with more than one complication
++ No. of patients with only one complication
+++ Total no. of patients with only one complication
# No. of patients with no complications
** Total no. of patients with no complications
*** Total no. of complications in each group
**** Total no. of patients in each group
development of increased pulmonary vascular resistance, the
optimal time of repair is unclear.14
Looking at the outcomes of our study, although there
was no significant difference in the number of patients who
had complications among the two groups, the total number of
complications was significantly different. This is expected as
younger children are more likely to report with increasing
complications. Children of increasing age ( 2-18 years), if they
survive are likely to develop physiological changes that suit
them, hence they are expected to report with less
complications compared to infants.  However, our mortality
rate was (5.1%) which is much higher than the rates reported
recently from the developed nations (<1%).5,14,15,18 Studies
from developed countries have shown that in term infants,
young age is not a risk factor for adverse postoperative
outcomes after surgical closure of large VSDs.8-14However, in
our study, there is clearly a difference in the postoperative
recovery times (duration of mechanical ventilation and ICU
stay) and a higher rate of infectious complications, assessed by
the development of fever, pneumonia and wound infections. It
can also be proposed that the slower recovery of such patients
is, in part, from longer durations of CPB. Earlier studies done
from the developing world19 also report similar postoperative
recovery times, although their rate of mortality was higher
(6%) than reported by us. 
In conclusion, we believe that once infants with
symptomatic VSDs reach 6 months of age, early surgical
intervention should be done. Our data clearly shows that
earlier intervention can be undertaken safely and effectively in
smaller children without adversely affecting outcomes.
Although both the mortalities were from the infant group, their
condition was already severe, and a larger study sample could
relate better to this issue. Performing surgery earlier can avoid
unnecessary aggressive medical management with increased
diuretics, high caloric feeds, or even risk of developing
pulmonary vascular disease. More studies should be
undertaken to point out the exact correlation between peri-
operative variables and the development of complications;
and assess whether these factors play any role in decreasing
the immediate as well as long term complication rate of
individuals.
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